Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEurocell Regulatory News (ECEL)

Share Price Information for Eurocell (ECEL)

Share Price is delayed by 15 minutes
Get Live Data
103.00    -6.50 (-5.94%)
Bid:
104.50
Ask:
109.50
Spread: 5.00 (4.785%)
Market Cap: £101.51m
ECEL Live PriceLast checked at - London Stock Exchange

Intraday Eurocell Share Chart

Trading Update

13 Jul 2022 07:00

RNS Number : 2456S
Eurocell plc
13 July 2022
 

13 July 2022

EUROCELL PLC

("Eurocell" or the "Group")

 

Trading Update - Good First Half and Trading in Line with Expectations

 

Eurocell plc, the market leading, vertically integrated UK manufacturer, recycler and distributor of innovative window, door and roofline PVC products, provides the following update for the six months ended 30 June 2022.

 

Trading Performance

The repair, maintenance and improvement (RMI) market remains robust, with a greater emphasis on project specific work, rather than the higher levels of maintenance activity experienced last year. A backlog in planning permissions, driven by house moves, as well as hybrid working and changing lifestyle patterns, continue to support sales, partly funded by elevated levels of consumer savings. In new build, the market continues to be strong, supported by ongoing Government initiatives.

 

Our sales growth rates for the six months to 30 June 2022 were as follows:

 

Sales growth

vs 2021

vs 2019

Total Group

13%

40%

Profiles Division

17%

39%

Building Plastics Division

11%

40%

 

We have kept pace with an exceptionally strong comparative period and have made substantial progress compared to the equivalent period of 2019. We continue to take effective action to offset input cost inflation, with a dynamic approach to selling price increases and surcharges. Price therefore remains a key driver of sales growth, but we believe resin costs have now plateaued.

 

We believe we are continuing to take market share, reflecting the impact of maturing branches, a widening product range (including our outdoor living range of fencing, decking and garden rooms) and excellent customer service, supported by our recent investments in manufacturing and warehousing capacity and technology, where operating efficiencies are improving. Our pipeline of potential new fabricator customers is strong.

 

As a result of these factors, and notwithstanding uncertainty over how the macroeconomic backdrop may impact future demand, we continue to trade in line with expectations.

 

Net debt at 30 June 2022 on a pre-IFRS 16 basis was £15 million (31 December 2021: £11 million), which includes the substantial impact of inflation on working capital.

 

Half Year Results

We look forward to providing a full update when we announce our half year results for the six months ending 30 June 2022 on 1 September 2022.

 

 

Enquiries:

Eurocell plc

 

Mark Kelly, Chief Executive Officer

+44 (0) 1773 842 105

Michael Scott, Chief Financial Officer

+44 (0) 1773 842 140

 

 

Teneo

 

Ben Foster

+44 (0) 777 624 0806

Camilla Cunningham

+44 (0) 746 498 2426

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBRGDRLXBDGDD
Date   Source Headline
15th Feb 20246:00 pmRNSHolding(s) in Company
15th Feb 20247:00 amRNSTransaction in Own Shares
14th Feb 20247:00 amRNSTransaction in Own Shares
13th Feb 20247:00 amRNSDirector/PDMR Shareholding
13th Feb 20247:00 amRNSTransaction in Own Shares
8th Feb 20247:00 amRNSTransaction in Own Shares
7th Feb 20247:00 amRNSTransaction in Own Shares
6th Feb 20247:00 amRNSTransaction in Own Shares
5th Feb 20247:00 amRNSTransaction in Own Shares
2nd Feb 20247:00 amRNSTransaction in Own Shares
1st Feb 20247:00 amRNSTransaction in Own Shares
1st Feb 20247:00 amRNSNon-executive Directors' Share Purchase Plan
30th Jan 20247:04 amRNSTransaction in Own Shares
29th Jan 20247:00 amRNSTransaction in Own Shares
26th Jan 20247:00 amRNSTransaction in Own Shares
25th Jan 20247:00 amRNSDirectorate Change
25th Jan 20247:00 amRNSTransaction in Own Shares
24th Jan 20247:00 amRNSTransaction in Own Shares
23rd Jan 20247:00 amRNSYear End Trading Update
23rd Jan 20247:00 amRNSLaunch of Share Buyback Programme
27th Dec 20237:00 amRNSHolding(s) in Company
19th Dec 20234:30 pmRNSHolding(s) in Company
29th Nov 20234:30 pmRNSDirector/PDMR Shareholding
14th Nov 20234:30 pmRNSDirector/PDMR Shareholding
3rd Nov 20234:30 pmRNSHolding(s) in Company
2nd Nov 20237:00 amRNSDirector/PDMR Shareholding
16th Oct 20234:30 pmRNSHolding(s) in Company
16th Oct 20234:30 pmRNSDirector/PDMR Shareholding
13th Oct 20234:30 pmRNSHolding(s) in Company
22nd Sep 20237:00 amRNSInvestor Presentation
21st Sep 20234:30 pmRNSDirector/PDMR Shareholding
7th Sep 20236:30 pmRNSDirector/PDMR Shareholding
5th Sep 20237:00 amRNSHalf-year Results
4th Sep 20237:00 amRNSBlock listing Interim Review
9th Aug 20234:30 pmRNSDirector/PDMR Shareholding
25th Jul 20237:00 amRNSTrading Update - In Line with Expectations
17th Jul 20237:00 amRNSHolding(s) in Company
18th May 20237:00 amRNSHolding(s) in Company
16th May 20234:00 pmRNSHolding(s) in Company
16th May 20237:00 amRNSHolding(s) in Company
15th May 20235:00 pmRNSChanges to Board Committee Memberships
12th May 20237:00 amRNSTrading Update and Board Changes
11th May 20234:30 pmRNSResult of AGM
10th May 20237:00 amRNSDirector/PDMR Shareholding
24th Apr 20237:00 amRNSDirector/PDMR Shareholding
17th Apr 20237:00 amRNSDirector/PDMR Shareholding
13th Apr 20237:00 amRNSDirector/PDMR Shareholding
11th Apr 20237:00 amRNSAnnual Financial Report
20th Mar 20237:00 amRNSInvestor Presentation
17th Mar 20237:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.